Softigel® by Procaps is a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry. Through our extensive capabilities and deep expertise in product development and softgel manufacturing, we help different companies bring innovative products to their markets faster, offering their patients and consumers an exceptional experience, high preference and superior adherence to different therapies.  Our advanced delivery technologies, including Softgel and related technologies, our proven formulation, manufacturing and regulatory expertise, has enabled us to become an integrated CDMO (iCDMO), giving customers full-service, turnkey solutions in prescription drugs, OTC and dietary supplements across both development and delivery.   Our differentiating strengths enable us to move into more difficult-to-produce compounds, formulations, dosage forms, and non-traditional manufacturing processes where few competitors can follow. Our Company is infused with a strong belief in the growing need for precisely the sort of generic drugs, specialty Pharma products, and advanced delivery technologies positioned in our pipeline, so developing long-term partnerships based on these breakthrough technologies is our state of mind.

Related Categories

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)